Please assess the completion status of the following clinical trial:

Trial Title: Botox Cosmetic and the Young Patient With Glabellar Furrows

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* Fitzpatrick Skin Types I-III~* Between 30 and 50 years of age~* At least moderate severity at maximum frown~Exclusion Criteria:~* Prior botulinum toxin treatment~* Any disorder (such as myasthenia gravis, Eaton-Lambert syndrome) or agent (such as aminoglycoside antibiotics) that might interfere with neuromuscular function~* Any other condition or situation that might put the subject at significant risk, confound the study results (such as significant pre-existing brow or eyelid ptosis)~* Allergy or sensitivity to any study component~* Participation in another clinical study within 30 days of the study start date~* Are planning other facial cosmetic procedures during the study period, or are pregnant, breastfeeding, or planning a pregnancy during the study.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Botox (Type: EXPERIMENTAL): Botox Cosmetic will be delivered in standard doses of 4 units per injection site over a total of 5 sites, thus treating the procerus and corrugator superciliaris muscle groups

Based on this trial design, predict the completion outcome and termination type (if applicable).